NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma

por Miftah, Hayat, Naji, Oumayma, Ssi, Saadia Ait, Ghouzlani, Amina, Lakhdar, Abdelhakim, Badou, Abdallah
Publicado 2023

A(2A)R as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma

por Rafii, Soumaya, Ghouzlani, Amina, Naji, Oumayma, Ait Ssi, Saadia, Kandoussi, Sarah, Lakhdar, Abdelhakim, Badou, Abdallah
Publicado 2023

Deciphering immune microenvironment and cell evasion mechanisms in human gliomas

por Rafii, Soumaya, Kandoussi, Sarah, Ghouzlani, Amina, Naji, Oumayma, Reddy, Konala Priyanka, Ullah Sadiqi, Rizwan, Badou, Abdallah
Publicado 2023